Prosjekter finansiert av KLINBEFORSK

Prosjekter finansiert etter utlysning i 2018:

ProsjektProsjektleder /
Koordinerende institusjon
(mill. kroner)
The REMNANT study – does early treatment of relapse increase survival in myeloma?Fredrik H. Schjesvold /
Oslo universitetssykehus HF
The ReSScue study; clinical and mechanistic effects of transplanting a standard cultivated gut microbiome in patients with Systemic SclerosisØyvind Molberg /
Oslo universitetssykehus HF
Urine based surveillance of bladder cancer patientsGuro E. Lind /
Oslo universitetssykehus HF
Fecal Transplantation for Primary Clostridium Difficile InfectionMichael Bretthauer /
Oslo universitetssykehus HF
Proteasome blockade to sensitize glioblastoma with unmethylated MGMT promoter to temozolomide chemotherapyDorota Goplen /
Helse Bergen HF
Acceptance and commitment therapy with and without enhanced mindfulness training for chronic pain: A randomized controlled efficacy and mediator studyPetter Christian Borchgrevink /
St.Olavs Hospital HF
The Norwegian Trial of Physical Exercise After Myocardial Infarction - NORExKåre Bønaa /
St.Olavs Hospital HF

Prosjekter finansiert etter utlysning i 2017:

ProsjektProsjektleder /
Koordinerende institusjon
(mill. kroner)
BACK-TO-BASIC - a study of the effect of infliximab on patients with long-term lower back pain and Modic changesJohn-Anker Zwart / Oslo universitetssykehus HF17.9
Establishment of Molecular profiling for Individual clinical routine Treatment decisions in Early Breast Cancer (EMIT)Bjørn Naume / Oslo universitetssykehus HF20.0
BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic functionDan Atar / Oslo universitetssykehus HF15.0
Improved prediction of outcome by global strain and mechanical dispersion in patients with myocardial infarction, heart failure and primary prophylactic internal defibrillatorThor Edvardsen / Oslo universitetssykehus HF17.8
Changing the specialist mental health careGerd Kvale / Helse Bergen HF20.0
Immunotherapy for Hematological Malignancies- A Path to CureHenrik Hjorth-Hansen / St.Olavs Hospital HF5.7
Innovative steroid treatment to reduce asthma development in first-time rhinovirus induced wheezing – INSTARHenrik Døllner / St.Olavs Hospital HF 20.0
Sphenopalatine ganglion block in chronic migraine (MIBLOCK)Anders Mattias Linde / St.Olavs Hospital HF18.7

Prosjekter finansiert etter utlysning i 2016:

Koordinerende institusjon
(mill. kroner)
The Norwegian Antibiotics for Pneumonia in Children
(NAPiC) study
Håvard Ove
Skjerven / Oslo universitetssykehus HF
The ASAC-study: Acetylsalisylic Acid as Secondary
Prevention in Colorectal Cancer
Bjørn Atle
Bjørnbeth / Oslo universitetssykehus HF
The Nor-DRUM STUDY: assessing the effectiveness
of tailoring infliximab treatment by therapeutic drug
Espen Andre
Haavardsholm / Diakonhjemmet Sykehus AS
PRevention of cArdiac Dysfunction during Adjuvant
breast cancer therapy (PRADA-2)
Torbjørn Omland / Akershus universitetssykehus HF20.0
Randomized autologous hematopoietic stem cell
transplantation vs. Alemtuzumab for patients with
relapsing remitting Multiple sclerosis (RAM-MS)
Lars Bø / Helse Bergen HF20.0
A Phase 1b/2 clinical trial with Axl kinase inhibitor
BGB324 in combination with Dabrafenib/Trametinib or
Pembrolizumab in Metastatic Melanoma: Identification
of predictive markers of response
Straume / Helse Bergen HF
Tenecteplase in wake-up ischaemic stroke trial – TWISTEllisiv B.
Mathiesen / UNN HF